Mode
Text Size
Log in / Sign up

5-ALA PDT improves overall response and HPV clearance in cervical squamous intraepithelial lesionsPhotodynamic therapy shows promise for cervical squamous intraepithelial lesions

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider 5-ALA PDT as an effective option for cervical squamous intraepithelial lesions to improve response rates and HPV clearance.

This meta-analysis evaluated the efficacy of 5-aminolevulinic acid photodynamic therapy (5-ALA PDT) in patients with cervical squamous intraepithelial lesion (SIL). The study included a total sample size of 3,354 and compared 5-ALA PDT against observation, ablation, and conization.

The meta-analysis found that 5-ALA PDT resulted in an overall response rate (ORR) higher than both observation (OR=10.27; 95% CI: 3.87-27.27) and ablation (OR=2.57; 95% CI: 2.00-3.30). There was no significant difference in ORR when compared to conization. Additionally, the HPV clearance rate at 6 months was higher than observation (OR=11.47; 95% CI: 3.16-41.68) and ablation (OR=1.46; 95% CI: 1.01-2.13), while remaining comparable to conization.

Regarding secondary outcomes, the risk of progression was lower than observation (OR=0.19; 95% CI: 0.11-0.34), and the recurrence rate was lower than ablation (OR=0.30; 95% CI: 0.14-0.63). Analysis by lesion grade showed a higher ORR in HSIL (0.91) compared to LSIL (0.86) with a p-value of 0.0289.

Clinical evidence suggests that 5-ALA PDT may improve ORR and HPV clearance relative to observation and ablation, while demonstrating efficacy comparable to conization. Only mild adverse events were reported.

How this fits prior evidence

This meta-analysis addresses a gap in the management of cervical squamous intraepithelial lesions by evaluating 5-ALA PDT compared to standard treatments like conization, ablation, and observation. While previous evidence confirmed high pooled complete response rates for ALA/MAL photodynamic therapy in superficial BCC, this study specifically evaluates its efficacy in cervical SIL. It confirms that 5-ALA PDT provides superior outcomes over observation and ablation regarding ORR and HPV clearance.

Dealing with cervical squamous intraepithelial lesions (SIL) can be stressful because these are precancerous changes in the cervix. Doctors are looking for ways to treat these areas effectively while clearing the underlying human papillomavirus (HPV). A large review of data involving over 3,000 patients looked at a specific treatment called 5-aminolevulinic acid photodynamic therapy (5-ALA PDT).

The results show that this light-based therapy performed better than just watching the condition or using simple ablation. It also showed similar success rates to conization, which is a surgical procedure to remove tissue. Specifically, patients receiving the 5-ALA treatment had higher response rates and were more likely to clear their HPV infection after six months compared to those who only received observation or ablation.

While the treatment was associated with only mild side effects, it is important to note that this data comes from a meta-analysis of multiple studies. While the results are promising for improving outcomes and lowering the risk of progression, you should talk to your doctor about how these findings apply to your specific health needs.

What this means for you:
5-ALA photodynamic therapy shows higher success rates and better HPV clearance than observation or ablation.

Common questions

How does this treatment compare to other options?

The study found that 5-aminolevulinic acid photodynamic therapy (5-ALA PDT) had a higher response rate and better HPV clearance than observation or ablation. Its success was comparable to conization, which is a surgical method used to treat these lesions.

Is this treatment safe for patients?

The data reported that patients who underwent the 5-ALA photodynamic therapy experienced only mild adverse events. No serious safety issues were reported in the study, making it a tolerable option for those with cervical squamous intraepithelial lesions.

Does this treatment help clear HPV infections?

Yes, the results showed that 5-ALA photodynamic therapy led to higher HPV clearance rates at the six-month mark compared to observation or ablation. The rates were similar to those seen with conization.

Study Details

Study typeMeta analysis
Sample sizen = 3,354
EvidenceLevel 1
Follow-up6.0 mo
PublishedJul 2026
View Original Abstract ↓
To evaluate the efficacy and safety of 5-aminolevulinic acid photodynamic therapy (5-ALA PDT) for cervical squamous intraepithelial lesion (SIL). We systematically searched PubMed and other databases to compare the effectiveness of 5-ALA PDT with observation, ablation, and conization. Outcomes included overall response rate (ORR), complete remission (CR) rate, HPV clearance rate, and other relevant endpoints. Single-arm analyses were additionally performed by lesion grade. A total of 3,354 patients were included across 19 studies. The ORR with PDT was significantly higher than with observation (OR = 10.27, 95% CI: 3.87-27.27) and ablation (OR = 2.57, 95% CI: 2.00-3.30), with no significant difference compared with conization. At 6 months, HPV clearance rate was significantly higher with PDT than with observation (OR = 11.47, 95% CI: 3.16-41.68) and ablation (OR = 1.46, 95% CI: 1.01-2.13), but was comparable to conization. PDT also associated with a lower risk of progression than observation (OR = 0.19, 95% CI: 0.11-0.34) and a lower recurrence rate than ablation (OR = 0.30, 95%CI 0.14-0.63). ORR was 0.86 (95% CI: 0.83-0.89) in LSIL and 0.91 (95% CI: 0.87-0.94) in HSIL, with a significant difference between groups (P = 0.0289). 5-ALA PDT for cervical SIL improves ORR and HPV clearance compared with observation and ablation, with efficacy comparable to conization and only mild adverse events. It is effective across lesion grades, with slightly better responses in HSIL.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.